From inflammation to renal fibrosis: A one-way road in autoimmunity?

Autoimmun Rev. 2024 Apr;23(4):103466. doi: 10.1016/j.autrev.2023.103466. Epub 2023 Oct 15.


Renal fibrosis is now recognized as a main determinant of renal pathology to include chronic kidney disease. Deposition of pathological matrix in the walls of glomerular capillaries, the interstitial space, and around arterioles predicts and contributes to the functional demise of the nephron and its surrounding vasculature. The recent identification of the major cell populations of fibroblast precursors in the kidney interstitium such as pericytes and tissue-resident mesenchymal stem cells, or bone-marrow-derived macrophages, and in the glomerulus such as podocytes, parietal epithelial and mesangial cells, has enabled the study of the fibrogenic process thought the lens of involved immunological pathways. Besides, a growing body of evidence is supporting the role of the lymphatic system in modulating the immunological response potentially leading to inflammation and ultimately renal damage. These notions have moved our understanding of renal fibrosis to be recognized as a clinical entity and new main player in autoimmunity, impacting directly the management of patients.

Keywords: Autoimmunity; Inflammation; Renal fibrosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmunity* / immunology
  • Fibrosis*
  • Humans
  • Inflammation* / immunology
  • Inflammation* / pathology
  • Kidney / immunology
  • Kidney / pathology
  • Kidney Diseases / immunology
  • Kidney Diseases / pathology